VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
UNH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
UNHUnitedHealth Group Incorporated
$389.68$353.9B
Overview & Tools
OverviewChart Terminal ↗AnalysisVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksUNHCash Flow

UnitedHealth Group Incorporated (UNH) Cash Flow Statement

30Y historyFree accessUpdated daily

Operating cash flow ranged from $1.1B in 2025Q4 to $13.9B in 2024Q3 and claims outflows rose to $90.7B in 2026Q3, indicating that cash conversion appears more tied to claims payment timing than to underlying earnings power, while dividends of roughly $2.0B per quarter remain steady.

Income StatementBalance SheetCash FlowRatios

UNH Cash Flow Statement

Annual statement

UNH Cash Flow Statement

UnitedHealth Group Incorporated (UNH) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations26.2B19.7B24.2B29.07B26.21B22.34B22.17B18.46B15.71B13.6B9.79B9.74B8.05B6.99B7.16B6.97B6.27B5.63B4.24B5.88B6.53B4.33B4.13B3B2.42B1.84B1.52B1.19B1.07B683M562.26M
Operating CF Growth %50.04%-18.62%-16.73%10.92%17.29%0.76%20.1%17.5%15.57%38.81%0.56%20.98%15.16%-2.29%2.68%11.08%11.52%32.73%-27.89%-9.94%50.86%4.62%37.7%23.94%31.4%21.24%27.92%11.02%56.81%21.47%29.47%
Operating CF / Revenue %5.83%4.4%6.05%7.82%8.08%7.77%8.62%7.62%6.95%6.76%5.3%6.2%6.17%5.71%6.47%6.84%6.66%6.46%5.22%7.79%9.12%9.32%11.11%10.51%9.68%7.86%7.2%6.08%6.17%5.79%5.58%
Net Income15.88B12.81B15.24B22.38B20.12B17.29B15.77B13.84B11.99B10.56B7.02B5.81B5.62B5.63B5.53B5.14B4.63B3.82B2.98B4.65B4.16B3.3B2.59B1.82B1.35B913M736M568M-166M460M355.64M
Depreciation & Amortization4.26B4.36B4.1B3.97B3.4B3.1B2.89B2.72B2.43B2.25B2.06B1.69B1.48B1.38B1.31B1.12B1.06B991M981M796M670M453M374M299M255M265M247M233M185M146M133.17M
Stock-Based Compensation1.02B971M1.02B1.06B925M800M679M697M638M597M485M406M364M331M421M401M326M334M305M505M404M0000000000
Deferred Taxes380M-989M-296M-245M-673M-814M-60M230M42M-748M81M-308M-415M1M5M-8M248M7M-166M-127M-267M167M125M91M154M40M73M35M-184M91M0
Other Non-Cash Items397M265M4.95B258M188M447M0294M325M265M-26M55M0-35M0000-122M00000-506M-287M-465M-353M-98M14M704K
Working Capital Changes3.47B2.28B-808M1.64B2.25B1.52B2.9B683M294M679M183M2.08B1B-306M-106M309M1M471M263M49M1.56B406M1.05B788M1.17B913M930M706M1.33B-28M72.75M
Cash from Investing-11.43B-8.69B-20.53B-15.57B-28.48B-10.37B-12.53B-12.7B-12.38B-8.6B-9.36B-18.39B-2.53B-3.09B-8.65B-4.17B-5.34B-976M-5.07B-4.15B-2.1B-3.49B-1.64B-745M-1.39B-1.14B-968M-623M21M-1B-472.51M
Capital Expenditures-3.37B-3.62B-3.5B-3.39B-2.8B-2.45B-2.05B-2.07B-2.06B-2.02B-1.71B-1.56B-1.45B-1.16B-1.07B-1.07B-878M-739M-791M-871M-728M-509M-350M-352M-419M-425M-245M-196M-210M-187M-165.22M
Acquisitions-1.61B-4.51B-13.41B-10.14B-21.46B-4.82B-7.14B-8.34B-6B-2.13B-1.76B-16.16B-1.92B-317M-6.28B-1.41B-2.3B-486M-3.81B-262M-670M-2.92B-2.23B-590M-302M-92M-76M-334M-464M0-51.86M
Purchase of Investments945M0-27.31B-18.31B-18.82B-1.84B-16.58B-2.5B-4.1B-4.32B-5.93B-531M-9.93B-1.61B-1.3B-9.89B-2.16B-6.47B-9.25B-6.38B-4.85B-5.88B-3.19B-2.58B-3.25B-2.09B-3.02B-2.21B-2.8B-6.71B-5.01B
Sale/Maturity of Investments-6.73B361M27.83B16.54B11.99B15.3B13.74B15.63B9.91B10.27B11.62B9.41B799M10.56B8.6B8.2B5.7B249M8.6B3.37B4.1B5.82B4.12B2.78B2.58B1.47B2.36B2.06B3.44B5.89B4.75B
Other Investing-667M-915M-4.14B-275M2.62B-16.55B-506M-15.41B-10.14B-10.39B-11.58B-9.55B9.96B-10.56B-8.6B0-5.7B6.47B185M052M0000012M51M59M0-1.5M
Cash from Financing-16.06B-11.64B-3.51B-11.53B4.23B-7.46B-3.59B-5.63B-4.37B-3.44B-1.01B12.24B-5.29B-4.95B471M-2.49B-1.61B-2.27B-605M-3.19B474M593M-762M-1.13B-1.44B-585M-739M-605M-198M34M6.86M
Dividends Paid-8.17B-7.92B-7.53B-6.76B-5.99B-5.28B-4.58B-3.93B-3.32B-2.77B-2.26B-1.79B-1.36B-1.06B-820M-651M-449M-36M-37M-40M-41M-19M-18M-9M-9M-9M-5M-6M-34M-35M-34.09M
Share Repurchases-9.77B-5.54B-9B-8B-7B-5B-4.25B-5.5B-4.5B-1.5B-1.28B-1.2B-4.01B-3.17B-3.08B-2.99B-2.52B-1.8B-2.68B-6.6B-2.35B-2.56B-3.45B-1.61B-1.81B-1.13B-1.18B-983M-436M-16M0
Stock Issued-444M01.85B1.35B1.25B1.35B1.44B1.04B838M688M429M402M462M598M1.08B381M272M282M299M712M397M423M583M268M205M178M228M102M84M79M41.56M
Debt Issuance (Net)-2M1000K1000K1000K1000K1000K1000K1000K1000K-1000K1000K1000K1000K1000K1000K1000K1000K-1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K0-620K
Other Financing8.14B1.09B-3.48B-2.4B3.43B344M2.66B-187M-679M3.45B1.54B618M-314M-872M-1.27B428M989M729M682M-827M1.89B90M75M4M000006M0
Net Change in Cash2.39B2.81B-115M2.06B1.99B4.45B5.94B119M-1.11B1.55B-493M3.43B219M-1.13B-1.02B306M-677M2.37B-1.44B-1.46B4.9B1.43B1.73B1.13B-410M121M-186M-39M894M-287M96.61M
Exchange Rate Effect3.69B3.44B-280M97M34M-62M-116M-20M-78M-5M78M-156M-5M-86M00000000000000000
Cash at Beginning28.59B25.31B25.43B23.36B21.38B16.92B10.98B10.87B11.98B10.43B10.92B7.5B7.28B8.41B9.43B9.12B9.8B7.43B8.87B10.32B5.42B3.99B2.26B1.13B1.54B1.42B1.6B1.64B750M1.04B940.11M
Cash at End25.84B28.12B25.31B25.43B23.36B21.38B16.92B10.98B10.87B11.98B10.43B10.92B7.5B7.28B8.41B9.43B9.12B9.8B7.43B8.87B10.32B5.42B3.99B2.26B1.13B1.54B1.42B1.6B1.64B750M1.04B
Free Cash Flow22.83B16.07B20.7B25.68B23.4B19.89B20.12B16.39B13.65B11.57B8.09B8.18B6.6B5.83B6.08B5.95B5.39B4.89B3.45B5.01B5.8B3.82B3.79B2.65B2B1.42B1.28B993M861M496M397.04M
FCF Growth %31.4%-22.36%-19.38%9.73%17.67%-1.16%22.76%20.09%17.95%43.05%-1.15%23.92%13.28%-4.19%2.27%10.29%10.42%41.75%-31.14%-13.66%51.9%0.85%42.78%32.29%41.23%11.21%28.5%15.33%73.59%24.93%22.15%
FCF Margin %5.08%3.59%5.17%6.91%7.22%6.92%7.83%6.77%6.03%5.75%4.38%5.21%5.06%4.76%5.5%5.84%5.73%5.61%4.25%6.64%8.1%8.22%10.17%9.28%8.01%6.05%6.04%5.08%4.96%4.21%3.94%
FCF per Share25.3117.6622.2927.3824.6420.820.9416.9713.8911.758.368.466.75.75.825.474.774.142.783.684.142.862.882.151.581.090.950.70.560.320.27

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Medicare Advantage utilization and DOJ scrutiny

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Claims Outflows Dominate Quarterly Cash Profile

According to reported quarterly figures, UNH's claims and loss payments rose from $75.4B in 2026Q2 to $90.7B in 2026Q3, and this step-up in cash outflow appears to be consuming most of the premium inflow base during the period.

The quarterly claims outflow series is large relative to net income, which suggests cash generation is highly sensitive to the timing of medical payments versus premium receipts. The spike in 2026Q3 aligns with the utilization pressures noted in the prior income statement review and may indicate that Medicare Advantage cost trends are outpacing pricing. Investors should monitor whether this payment cadence reflects seasonal or structural utilization shifts, as sustained elevation would weigh on float-driven cash generation.

Operating Cash Flow Swings Track Reserve Timing

Based on UNH's reported figures, operating cash flow ranged from $1.1B in 2025Q4 to $13.9B in 2024Q3, a volatility pattern that appears more closely tied to claims payment timing than to underlying earnings power.

The OCF to net income ratio moved from 0.43 to 2.30 across the ten-quarter window, and in 2025Q4 the ratio of 110.80 reflects a near-zero net income base rather than meaningful cash generation. This pattern suggests that quarterly operating cash flow is being driven by reserve build and release dynamics rather than steady premium-to-claims conversion. Trailing cash generation may therefore be a more reliable gauge than any single quarter.

Investment Portfolio Rebalancing Drives Liquidity

As reported in the cash flow statements, UNH shifted from net purchases of $14.1B in 2025Q3 to net sales of $14.1B in 2025Q4, indicating active rotation of the investment float rather than a static holding pattern.

Large swings between purchases and sales of investments suggest management is actively managing portfolio duration and liquidity against claims obligations. The 2025Q4 sale activity coincides with weak net income, which may indicate that portfolio liquidation was used to fund claims payments or capital returns. Investors should note that the realized yield and the pace of reinvestment are not disclosed here, limiting assessment of the income effect of these moves.

Dividend Coverage Stable but Buybacks Irregular

Based on reported cash flows, UNH paid steady dividends of roughly $1.9B to $2.1B per quarter across the window, while buybacks varied from zero to $5.0B, making repurchase activity the less predictable component of capital return.

Dividend outflows remained consistent even as quarterly net income fell near zero in 2025Q4, which suggests the payout is supported by cash flow rather than current earnings. Buybacks, by contrast, appear to flex with cash availability, and the $5.0B repurchase in 2024Q4 exceeded quarterly OCF in several periods. This implies that repurchases may be partly funded from portfolio liquidation, warranting monitoring of whether capital return remains self-funded over time.

Reported Cash Strength May Mask Reserve Risk

As reported in the quarterly cash flow data, UNH's trailing operating cash generation looks adequate, but the DOJ Medicare Advantage investigation and elevated utilization could weaken future float conversion in ways a beat-and-raise quarter does not resolve.

Quarterly operating cash flow can be lifted by reserve timing and claims payment lags, so a strong quarter such as 2024Q3 may overstate the sustainable conversion of premiums into cash. Based on the supplied data, unresolved regulatory exposure and potential overpayment recoveries are not quantified, and they may reduce future operating cash if penalties or repayments materialize. Investors should monitor whether operating cash flow holds up once claims normalize, rather than relying on the reported quarterly peaks.

UNH — Frequently Asked Questions

Quick answers to the most common questions about buying UNH stock.

How much cash does UnitedHealth Group Incorporated (UNH) generate from operations?

UnitedHealth Group Incorporated (UNH) generated $19.70B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is UnitedHealth Group Incorporated's free cash flow?

UnitedHealth Group Incorporated (UNH) generated $16.07B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is UnitedHealth Group Incorporated's capital expenditure (CapEx)?

UnitedHealth Group Incorporated (UNH) spent $3.62B on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does UnitedHealth Group Incorporated distribute cash to shareholders?

In 2025, UnitedHealth Group Incorporated (UNH) returned $7.92B to shareholders via cash dividends and spent $5.54B on share repurchases. This shows the company's commitment to returning capital to its equity investors.